Dodge & Cox International Stock Fund
Dodge & Cox Funds · Series S000011203 · 2 share classes
data updated 2026-08-17
Fund profile
As filed in the prospectus · 2026 Q2
The Fund seeks long-term growth of principal and income.
The fund invests in equity securities of non-U.S. companies from at least three countries, typically medium-to-large established firms that appear undervalued relative to their long-term profit growth prospects. The manager evaluates companies on financial strength, cash flow, competitive position, governance, and management quality alongside valuation. The fund maintains at least 80% of assets in non-U.S. equities and may use derivatives to hedge currency exposure or create equity market exposure from cash holdings.
| Share class | Gross | Net |
|---|---|---|
| DODFX | 0.61% | 0.61% |
| DOXFX | 0.56% | 0.51% |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 17.00% · as of 2026 Q2
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q1
| Stocks | 98.80% |
| Cash & short-term | 0.79% |
| Derivatives | 0.03% |
Derivatives are shown at market value, not notional exposure.
Latest quarter
What changed since the fund's previous filing
Largest new: Roche Holding AG, SUNB, Mitsubishi Electric Corp., London Stock Exchange Group PLC, Schneider Electric SE, Novo Nordisk A/S, Murata Manufacturing Co., Ltd., Reckitt Benckiser Group PLC
Largest exited: Roche Holding AG, Ashtead Group PLC, Mitsubishi Electric Corp., Reckitt Benckiser Group PLC, Schneider Electric SE, Murata Manufacturing Co., Ltd., NIDEC Corp., Amrize, Ltd.
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Feb 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| — | — | — | — | — | |
| — | — | — | — | — |
Mar 2026 has been filed since the trailing figures were struck, so it is not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| — | Taiwan Semiconductor Manufacturing Co., Ltd. | 3.80% | $56.38 | $2.32B | 41.2M |
| JCI | Johnson Controls International PLCJCI | 3.50% | $130.95 | $2.14B | 16.3M |
| GLAXF | GSK PLCGLAXF | 3.35% | $27.42 | $2.05B | 74.7M |
| — | BNP Paribas SA | 3.23% | $95.26 | $1.98B | 20.7M |
| — | TotalEnergies SE | 2.83% | $92.33 | $1.73B | 18.7M |
| — | Novartis AG | 2.69% | $151.83 | $1.64B | 10.8M |
| — | Banco Santander SA | 2.65% | $11.32 | $1.62B | 142.8M |
| — | Itau Unibanco Holding SA | 2.59% | $8.39 | $1.58B | 188.4M |
| — | Barclays PLC | 2.33% | $5.27 | $1.42B | 270.1M |
| SU | Suncor Energy, Inc.SU | 2.28% | $66.11 | $1.39B | 21.1M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-03-31 — not a live quote, and not what the fund paid.
Top 10 positions are 29.25% of net assets, top 25 53.30%, across 91 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free